AST SpaceMobile Rockets 20%, Planet Labs Soars 15%, Rocket Lab Climbs 6% as SpaceX IPO Lifts the Whole Sector

SpaceX’s pending IPO, framed around a roughly $1.75 trillion valuation and $18.674 billion in 2025 revenue, is driving a halo rally across public space names. AST SpaceMobile rose 20%, Planet Labs 15%, and Rocket Lab 6% as investors reassess the sector’s valuation benchmarks and rotate into space equities ahead of the listing. The move is supported by strong company-specific operating trends, including AST’s 60+ operator partners, Planet’s $81.25 million Q3 FY2026 revenue, and Rocket Lab’s $2.2 billion backlog.

Analysis

This is a classic pre-IPO sentiment cascade, but the second-order effect is not just beta expansion across the space basket — it is a forced re-ranking of “who deserves scarcity premium” versus “who is just participating in the category.” The highest near-term beneficiary is the name that most cleanly maps to SpaceX’s connectivity economics, while the most vulnerable are the companies whose equity stories depend on launch optics more than recurring monetization. That creates an asymmetric setup where the first move is momentum, but the post-listing move is likely dispersion.

The market is also likely underestimating how quickly the SpaceX listing can compress valuation multiples for public peers even if the IPO itself trades well. If SpaceX’s implied enterprise value is accepted by the market, investors will immediately compare revenue quality, EBITDA margins, and capital intensity across the public names, which should favor connectivity and data/software hybrids over pure launch exposure. The broader supply-chain spillover is mostly positive for low-cost orbit enablers, but negative for any launcher that can be framed as a weaker substitute for a vertically integrated incumbent.

The contrarian view is that the current rally may be front-running a benchmark event that is already widely understood, making the first derivative of sentiment exhausted before the first day of trading. In that case, the risk is not a collapse in fundamentals, but a rotation out of the most crowded halo beneficiaries once the tape starts to enforce relative value discipline. The move looks most fragile in the name with the weakest fundamental improvement versus the strongest crowd narrative support.

Catalyst timing matters: the next few sessions are about positioning and flows; the next 1-3 months will be about whether these companies can decouple via execution milestones. If they can’t, the SpaceX IPO becomes an anchor for comp resets rather than a rising-tide tailwind. That is especially relevant for the launch-heavy name, where any disappointment on launch cadence or program timing could quickly offset the current sympathy bid.

Key Decisions for Investors

• Short dated call spread on RKLB into the SpaceX listing window: buy 1-2 month bearish risk reversal or finance a put spread with out-of-the-money calls; thesis is that launch exposure becomes the first comp to de-rate once public pricing is available.
• Go long ASTS versus RKLB on a 2-6 week horizon: ASTS has the cleanest economic overlap with the highest-profile SpaceX segment, while RKLB is more exposed to relative valuation compression; target 10-15% outperformance if the halo trade persists.
• Take partial profits on PL after the gap move and re-enter only on pullbacks: the stock benefits from lower launch costs, but the current move likely embeds too much of the near-term sector rerating; better risk/reward is to buy weakness after the IPO event.
• If options liquidity allows, buy a calendar on ASTS around the BlueBird launch window: short near-dated elevated premium, long later-dated exposure; this captures the chance that event-driven flows outlast the initial SpaceX headline but keeps theta controlled.
• Use the SpaceX IPO date as a trigger to fade crowded longs in the basket if they gap further on the open: the trade should be reduced, not added to, if implied comp multiples detach materially from execution reality.